Funder
European Commission
European Regional Development Fund
Narodowym Centrum Nauki
Reference62 articles.
1. Anticancer therapeutic potential of benzofuran scaffolds;Abbas;RSC Adv.,2023
2. MCC1019, a selective inhibitor of the Polo-box domain of Polo-like kinase 1 as novel, potent anticancer candidate;Abdelfatah;Acta Pharm. Sin. B,2019
3. Synthesis and molecular docking study of new benzofuran and furo[3,2-g]chromone-based cytotoxic agents against breast cancer and p38alpha MAP kinase inhibitors;Amin;Bioorg. Chem.,2018
4. Biologically active Heterocyclic hybrids based on quinazolinone, benzofuran and imidazolium moieties: synthesis, characterization, cytotoxic and antibacterial evaluation;Asadi;Chem. Biodivers.,2017
5. Oxidative stress and lipid peroxidation products in cancer progression and therapy;Barrera;ISRN Oncology,2012